Fangzhou Inc.’s AI tool, XS LLM, was featured in Nature News for its potential in revolutionizing healthcare by managing chronic diseases. The model integrates image and speech recognition along with medical knowledge to offer personalized care. With over 50 million users and 200,000 physicians, the platform is a significant example of China’s AI innovation in global healthcare. Fangzhou aims to deepen AI research and expand applications to contribute to the “Healthy China 2030” initiative, addressing risks like “AI hallucination” through data refinements and regulatory compliance upgrades. Learn more about Fangzhou Inc. at https://investors.jianke.com.

Read more at GlobeNewswire: Fangzhou’s ‘XingShi’ LLM Featured by Nature News and